In a report released today, Louise Chen from Scotiabank maintained a Buy rating on Avidity Biosciences (RNA – Research Report), with a price ...

In a report released today, Louise Chen from Scotiabank maintained a Buy rating on Dyne Therapeutics (DYN – Research Report), with a price ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Zai Lab (ZLAB – Research Report), Perspective ...

JPMorgan raised the firm’s price target on Zai Lab (ZLAB) to $51 from $44 and keeps an Overweight rating on the shares. The firm updated models ...

Zai Lab (ZLAB) “announced that China’s National Medical Products Administration has accepted the Biologics License Application for TIVDAK, ...

Zai Lab (ZLAB – Research Report) received a Buy rating and a $55.00 price target from Scotiabank analyst Louise Chen today. The company’s ...

Cogent Biosciences (COGT – Research Report) received a Buy rating and a $17.00 price target from Scotiabank analyst Louise Chen today. The ...

Scotiabank initiated coverage of Zai Lab (ZLAB) with an Outperform rating and $55 price target The firm says that although geopolitical risk ...

Zai Lab (NASDAQ:ZLAB – Get Free Report)‘s stock had its “neutral” rating reiterated by research analysts at Bank of America in a note issued to investors on Monday, MarketBeat reports.

Shares of Zai Lab Limited Unsponsored ADR (ZLAB) have gained 15.9% over the past four weeks to close the last trading session at $31.73, but there could still be a solid upside left in the stock ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Zai Lab (ZLAB – Research Report) and ...